Product Code: ETC5630052 | Publication Date: Nov 2023 | Updated Date: Feb 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 | |
The preclinical imaging market in Israel includes the provision of imaging systems and services for non-invasive visualization and analysis of biological processes in preclinical research settings. Preclinical imaging modalities such as MRI, CT, PET, and optical imaging facilitate the study of disease mechanisms, drug efficacy, and treatment response in animal models, supporting drug development and biomedical research.
The Israel Preclinical Imaging market is witnessing significant growth attributed to the expanding applications in biomedical research, drug development, and disease modeling. Preclinical imaging modalities such as MRI, CT, PET, and optical imaging enable non-invasive visualization and quantification of biological processes in animal models. Moreover, the growing demand for translational research and personalized medicine drives innovation and investment in Preclinical Imaging in Israel.
The preclinical imaging market in Israel is challenged by high equipment costs, stringent regulatory requirements, and the need for highly skilled personnel to operate and interpret imaging results. There is also a constant demand for innovation to keep up with advancements in medical research.
The Israel government`s policies on the preclinical imaging market emphasize scientific research, technological innovation, and healthcare advancements. Measures support investments in imaging technologies used in drug development, disease research, and medical diagnostics. Regulatory frameworks ensure the safety, accuracy, and ethical use of preclinical imaging equipment. Collaboration with research institutions, healthcare providers, and technology developers promotes the advancement of imaging technologies and their applications in preclinical research.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Preclinical Imaging Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Preclinical Imaging Market Revenues & Volume, 2021 & 2031F |
3.3 Israel Preclinical Imaging Market - Industry Life Cycle |
3.4 Israel Preclinical Imaging Market - Porter's Five Forces |
3.5 Israel Preclinical Imaging Market Revenues & Volume Share, By Product, 2021 & 2031F |
3.6 Israel Preclinical Imaging Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 Israel Preclinical Imaging Market Revenues & Volume Share, By End Use, 2021 & 2031F |
4 Israel Preclinical Imaging Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Israel Preclinical Imaging Market Trends |
6 Israel Preclinical Imaging Market Segmentations |
6.1 Israel Preclinical Imaging Market, By Product |
6.1.1 Overview and Analysis |
6.1.2 Israel Preclinical Imaging Market Revenues & Volume, By CT Imaging, 2021-2031F |
6.1.3 Israel Preclinical Imaging Market Revenues & Volume, By MRI Imaging, 2021-2031F |
6.1.4 Israel Preclinical Imaging Market Revenues & Volume, By PET/SPECT Imaging, 2021-2031F |
6.1.5 Israel Preclinical Imaging Market Revenues & Volume, By Multi-modal Imaging, 2021-2031F |
6.1.6 Israel Preclinical Imaging Market Revenues & Volume, By Optical Imaging, 2021-2031F |
6.1.7 Israel Preclinical Imaging Market Revenues & Volume, By Ultrasound Imaging, 2021-2031F |
6.1.9 Israel Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.1.10 Israel Preclinical Imaging Market Revenues & Volume, By Reagents, 2021-2031F |
6.2 Israel Preclinical Imaging Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 Israel Preclinical Imaging Market Revenues & Volume, By Research and Development, 2021-2031F |
6.2.3 Israel Preclinical Imaging Market Revenues & Volume, By Drug Discovery, 2021-2031F |
6.3 Israel Preclinical Imaging Market, By End Use |
6.3.1 Overview and Analysis |
6.3.2 Israel Preclinical Imaging Market Revenues & Volume, By Biotech Companies, 2021-2031F |
6.3.3 Israel Preclinical Imaging Market Revenues & Volume, By Pharmaceutical companies, 2021-2031F |
6.3.4 Israel Preclinical Imaging Market Revenues & Volume, By Research institutes, 2021-2031F |
7 Israel Preclinical Imaging Market Import-Export Trade Statistics |
7.1 Israel Preclinical Imaging Market Export to Major Countries |
7.2 Israel Preclinical Imaging Market Imports from Major Countries |
8 Israel Preclinical Imaging Market Key Performance Indicators |
9 Israel Preclinical Imaging Market - Opportunity Assessment |
9.1 Israel Preclinical Imaging Market Opportunity Assessment, By Product, 2021 & 2031F |
9.2 Israel Preclinical Imaging Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 Israel Preclinical Imaging Market Opportunity Assessment, By End Use, 2021 & 2031F |
10 Israel Preclinical Imaging Market - Competitive Landscape |
10.1 Israel Preclinical Imaging Market Revenue Share, By Companies, 2024 |
10.2 Israel Preclinical Imaging Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |